Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × INDIV × Interventional × Clear all

Phase

Status

Completed 18 Unknown 11 Terminated 4 Recruiting 1 Not yet recruiting 1

Sponsor Class

OTHER 8764 INDUSTRY 2765 OTHER_GOV 234 NIH 205 NETWORK 136 FED 26 UNKNOWN 4 INDIV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Cancer 1

Interventions

pembrolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07123415 2025-11-19

A Phase 1 Study of APX-343A as Monotherapy or in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

Aptabio Therapeutics, Inc.

Phase 1 Recruiting

Other solid neoplasm

Advanced Solid Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡